Search results for: 'CCUS Digitalization Growth Opportunities'
-
23 Jan 2026  |  Global  |  Technology Research
Next-Generation Therapeutic Platforms: AI-Enabled Drug Discovery, Small molecules, Deep Proteomics, RNA Engineering, and Targeted Immunomodulation
Life Science, Health & Wellness Technology Opportunity Engine
This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) delivers provides strategic insights into breakthrough innovations shaping the future of healthcare, life sciences, and precision therapeutics. It highlights advances in AI-enabled diagnostics, metabolic reprogramming, small molecules, deep proteomics, RNA disco...
$950.00 -
15 Oct 2026  |  Global  |  Frost Radar
Frost Radar™: US and European Mammalian Contract Development and Manufacturing Organizations, 2026
A Benchmarking System to Spark Companies to Action - Innovation That Fuels New Deal Flow and Growth Pipelines
The US and European mammalian contract development and manufacturing organization (CDMO) market is entering a new phase of strategic evolution, driven by accelerating biologics outsourcing, increasing molecule complexity, and growing demand for resilient, end-to-end manufacturing partnerships. As monoclonal antibodies, bispecific antibodies, Fc-fus...
$4,950.00 -
01 Jun 2026  |  Global  |  Market Research
Biopharma Patient Access Market, Global, 2026
Access-Controlled Commercialization is Experiencing Transformational Growth due to Rising Specialty Therapy Complexity
The global biopharma patient access market is undergoing a structural shift as specialty medicines make downstream commercialization more complex and strategically important. Patient access is no longer limited to reimbursement support or hub services; it is becoming a commercialization control layer spanning authorization, affordability, therapy i...
$2,450.00 -
11 Jul 2025  |  Global  |  Market Outlook
Global Pharmaceutical Industry Outlook, 2025
Industry Convergence and Technology Adoption Lead to Transformational Growth
In this analysis, Frost & Sullivan identifies and defines the leading trends shaping the global pharmaceutical landscape. The study period is 2022–2030, with 2024 as the base year and 2025–2028 as the forecast period. The geographic scope includes 5 regions: North America, Latin America (LATAM) and the Caribbean, Asia-Pacific (APAC), Europe, and th...
$4,950.00
Special Price $4,455.00 save 10 %
-
05 Nov 2025  |  Global  |  Market Research
Global Pharmacovigilance and Safety Testing Outsourcing Services Market, Forecast to 2030
A Growing Focus on Precision Medicine and a Converging Ecosystem of Service Providers is Driving Market Growth
The global pharmaceutical industry strives to build an inclusive partner ecosystem that integrates technology, data, and regulatory standardization-enabled innovation into clinical trial delivery. This transformation aims to reduce the burden on investigators and sites while improving the efficiency and accuracy of adverse event (AE) tracking. Driv...
$4,950.00 -
15 May 2025  |  Global  |  Market Research
Immunomodulator Therapeutics Market, Global, 2024–2030
Mechanism-targeted Approaches are Driving Transformational Growth by Enabling Innovation in Autoimmune, Oncology, and Inflammatory Therapies
This research service offers a comprehensive analysis of the global immunomodulator therapeutics market, specifically targeting inflammatory disorders in the immunology, gastrointestinal (GI), and dermatology segments. The report defines this market through products designed to modify and regulate pathological immune responses, either by inhibiting...
$4,950.00
Special Price $4,455.00 save 10 %
-
18 May 2026  |  Global  |  Frost Radar
Frost Radar™: Smart Delivery Formulations for Biologics, 2026
A Benchmarking System to Spark Companies to Action - Innovation That Fuels New Deal Flow and Growth Pipelines
Biologics, particularly peptide and protein therapies, are a rapidly growing therapeutic area because they can target complex biological pathways with high efficacy. These therapies are becoming important in oncology, metabolic disease, and autoimmune conditions supported by the growing global disease burden and growth in areas such as GLP-1s and m...
$4,950.00 -
26 Nov 2025  |  Global  |  Market Research
Future of Bio-Pharma Industry, 2040
Adoption of Artificial Intelligence Is Driving Transformational Growth Across the Biopharma Value Chain
The biopharma industry has been evolving over the past few decades. This study analyses the top ten trends that will impact the future of the biopharma industry through 2040.The future of biopharma will be driven by innovation in AI and ML, particularly generative AI, and by advancements in translational medicine and synthetic biology. Future clini...
$2,450.00 -
23 May 2025  |  Global  |  Frost Radar
Frost Radar™: Life Sciences Real-World Evidence Solutions, 2025
A Benchmarking System to Spark Companies to Action - Innovation That Fuels New Deal Flow and Growth Pipelines
The evolving IT landscape has played a transformative role in the field of life sciences, enabling a reliance on real-world evidence (RWE) solutions. With growing competition and the demand for precision in decision-making, pharmaceutical companies, healthcare providers, and technology organizations have realized the need for real-world data (RWD) ...
$4,950.00
Special Price $4,455.00 save 10 %
-
02 Dec 2025  |  Global  |  Frost Radar
Frost Radar™: Antibody-Drug Conjugate Contract Development and Manufacturing Organizations, 2025
A Benchmarking System to Spark Companies to Action - Innovation That Fuels New Deal Flow and Growth Pipelines
This Frost Radar™ analyzes the competitive landscape of the antibody-drug conjugate (ADC) contract development and manufacturing organization (CDMO) market. Companies provide the foundational manufacturing and development services for what has become one of the most dynamic and valuable therapeutic modalities in oncology. The success of the ADC rev...
$4,950.00